1st Quarter - Report — ELI LILLY AND COMPANY for ELI LILLY AND COMPANY (2018)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

ELI LILLY AND COMPANY

Client

ELI LILLY AND COMPANY

Income

—

Expenses

$1,340,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
1st Quarter - Report (this page)	Apr 19, 2018	$1,340,000	Replaced
1st Quarter - Amendment	Jan 21, 2019	$1,340,000	Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Hospital discounts; 340B program

Lobbyist	Covered position, as disclosed
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—

Contacted: State, Dept of (DOS); Homeland Security, Dept of (DHS); Commerce, Dept of (DOC); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); SENATE; U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Natl Institutes of Health (NIH)

Copyright/Patent/Trademark CPT

Intellectual property

Lobbyist	Covered position, as disclosed
JESSE PRICE	—

Contacted: Food & Drug Administration (FDA); U.S. Trade Representative (USTR); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Office of Management & Budget (OMB); Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS); SENATE; Justice, Dept of (DOJ); Natl Institutes of Health (NIH)

Trade (domestic/foreign) TRD

Sanitary and phytosanitary issues (SPS); Japan; Turkey (country) Pricing; IPR and Pricing; Canada IP; NAFTA renegotiation; Colombia OELD Accession

Lobbyist	Covered position, as disclosed
ANJULEN ANDERSON REILLY	—
HARRISON C COOK	—
CATHERINE HINCKLEY	—
JESSE PRICE	—
JESSE SEVCIK	—
ERIC J. STEINER	—
DAVID TALBOT	—

Contacted: U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Agriculture, Dept of (USDA); Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Justice, Dept of (DOJ); State, Dept of (DOS); SENATE; Office of Management & Budget (OMB); Homeland Security, Dept of (DHS)

Taxation/Internal Revenue Code TAX

Tax reform

Lobbyist	Covered position, as disclosed
JESSE PRICE	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—
ERIC J. STEINER	—

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Office of Management & Budget (OMB); Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); Homeland Security, Dept of (DHS); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA)

Health Issues HCR

Patient protection; Drug shortages; Drug pricing and value; Dormant Therapies Act; PDUFA; BSUFA

Lobbyist	Covered position, as disclosed
JOE KELLEY	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—
DAVID TALBOT	—

Contacted: Commerce, Dept of (DOC); Office of Management & Budget (OMB); U.S. Trade Representative (USTR); State, Dept of (DOS); Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS)

Medicare/Medicaid MMM

Intellectual property; Dormant Therapies Act; 340B Program; Medicare Part B and Part D; PPACA; IPAB repeal

Lobbyist	Covered position, as disclosed
JESSE PRICE	—
JENNIFER ROMANS	—
SONYA SOTAK ELLING	—

Contacted: Justice, Dept of (DOJ); Homeland Security, Dept of (DHS); SENATE; State, Dept of (DOS); Office of Management & Budget (OMB); Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

Anti-counterfeiting; Patient safety; Drug pedigree; Serialization and traceability issues; Drug Quality and Security Act; Protecting consumers from illegal online drug sales; Promoting public-private partnerships; UN High Level Panel on Access to Medicines (UNHLP) and other multi-lateral threats to IP and the biopharmaceutical industry; Drug importation

Lobbyist	Covered position, as disclosed
JESSE PRICE	—
JENNIFER ROMANS	—

Contacted: Commerce, Dept of (DOC); SENATE; Natl Institutes of Health (NIH); Homeland Security, Dept of (DHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Justice, Dept of (DOJ); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); State, Dept of (DOS); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR)

Animals ANI

Issues related to animal health, antibiotics, veterinary medicine, and food safety - no specific legislation; Preservation of Antibiotics for Medical Treatment Act of 2017; Issues related to Animal Drug User Fee Act (ADUFA); Codex Alimentarius Commission (Food Safety, Animal Health Issues); Issues related to animal health and food safety - no specific legislation; Implementation of biotechnology policy - no specific legislation; Issues related to veterinary biologics - no specific legislation

Lobbyist	Covered position, as disclosed
ANJULEN ANDERSON REILLY	—
JESSE SEVCIK	—
ERIC J. STEINER	—

Contacted: Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Office of Management & Budget (OMB); SENATE; State, Dept of (DOS); U.S. Trade Representative (USTR); Justice, Dept of (DOJ); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Homeland Security, Dept of (DHS); Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.